Your browser doesn't support javascript.
loading
Sublingual dexmedetomidine (BXCL501) reduces opioid withdrawal symptoms: findings from a multi-site, phase 1b/2, randomized, double-blind, placebo-controlled trial.
Jones, Jermaine D; Rajachandran, Lavanya; Yocca, Frank; Risinger, Robert; De Vivo, Michael; Sabados, Jeff; Levin, Frances R; Comer, Sandra D.
Afiliação
  • Jones JD; Division on Substance Use Disorders, Department of Psychiatry, New York State Psychiatric Institute and Columbia University Irving Medical Center, New York, NY, USA.
  • Rajachandran L; BioXcel Therapeutics, Inc, New Haven, CT, USA.
  • Yocca F; BioXcel Therapeutics, Inc, New Haven, CT, USA.
  • Risinger R; BioXcel Therapeutics, Inc, New Haven, CT, USA.
  • De Vivo M; BioXcel Therapeutics, Inc, New Haven, CT, USA.
  • Sabados J; BioXcel Therapeutics, Inc, New Haven, CT, USA.
  • Levin FR; Division on Substance Use Disorders, Department of Psychiatry, New York State Psychiatric Institute and Columbia University Irving Medical Center, New York, NY, USA.
  • Comer SD; Division on Substance Use Disorders, Department of Psychiatry, New York State Psychiatric Institute and Columbia University Irving Medical Center, New York, NY, USA.
Am J Drug Alcohol Abuse ; 49(1): 109-122, 2023 01 02.
Article em En | MEDLINE | ID: mdl-36630319
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência a Substâncias / Dexmedetomidina / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência a Substâncias / Dexmedetomidina / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article